The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Published Online:https://doi.org/10.1176/ajp.128.11.1418

The authors conducted a three-week controlled, double-blind (methylphenidate-placebo) study of 31 hyperkinetic boys. Response to treatment was judged on the basis of improvement in pretreatment and posttreatment teacher ratings. Pretreatment measures indicated a high arousal state in those children who obtained a poor clinical response to methylphenidate. Changes in indicators of arousal suggested a greater physiological effect from methylphenidate treatment in the low-arousal (good clinical response) group. The authors' data suggest that genetic factors may play a major role in the etiology of this disorder; however, they stress the need for further research.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.